Growth Metrics

Fulgent Genetics (FLGT) Receivables (2016 - 2026)

Fulgent Genetics' Receivables history spans 12 years, with the latest figure at $69.3 million for Q1 2026.

  • On a quarterly basis, Receivables fell 6.4% to $69.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $69.3 million, a 6.4% decrease, with the full-year FY2025 number at $85.9 million, up 21.34% from a year prior.
  • Receivables hit $69.3 million in Q1 2026 for Fulgent Genetics, down from $85.9 million in the prior quarter.
  • Over the last five years, Receivables for FLGT hit a ceiling of $160.8 million in Q1 2022 and a floor of $13000.0 in Q3 2023.
  • Historically, Receivables has averaged $71.9 million across 5 years, with a median of $70.8 million in 2024.
  • Biggest five-year swings in Receivables: crashed 99.99% in 2023 and later surged 440784.62% in 2024.
  • Tracing FLGT's Receivables over 5 years: stood at $72.6 million in 2022, then fell by 27.74% to $52.5 million in 2023, then soared by 34.96% to $70.8 million in 2024, then grew by 21.34% to $85.9 million in 2025, then dropped by 19.35% to $69.3 million in 2026.
  • Business Quant data shows Receivables for FLGT at $69.3 million in Q1 2026, $85.9 million in Q4 2025, and $72.6 million in Q3 2025.